LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Maresca, Giovanna ^a   Natoli, Manuela ^a,f   Nardella, Marta ^a   Arisi, Ivan ^b   Trisciuoglio, Daniela ^c   Desideri, Marianna ^c   Brandi, Rossella ^b   D'Aguanno, Simona ^d   Nicotra, Maria Rita ^e   D'Onofrio, Mara ^b   Urbani, Andrea ^d   Natali, Pier Giorgio ^e   Del Bufalo, Donatella ^c   Felsani, Armando ^a   D'Agnano, Igea ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LAMIN A; LAMIN C; NEURITE PROMOTING FACTOR; RETINOIC ACID;

AGGRESSIVENESS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER GROWTH; NEURITE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LAMIN TYPE A; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEURITES; NEUROBLASTOMA; PROTEOME; TRETINOIN;

MUS MUSCULUS;

EID: 84866875446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045513     Document Type: Article

References (44)

1. Brodeur GM, (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
2. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116.
3. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, et al. (2001) International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92: 2451-2461.
4. Edsjo A, Holmquist L, Pahlman S, (2007) Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 17: 248-256.
5. Handler A, Lobo MD, Alonso FJ, Paino CL, Mena MA, (2000) Functional implications of the noradrenergic-cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells. J Neurosci Res 60: 311-320.
6. Goldman RD, Goldman AE, Shumaker DK, (2005) Nuclear lamins: building blocks of nuclear structure and function. Novartis Found Symp 264: 3-16.
7. Lammerding J, Lee RT, (2005) The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C deficient cells. Novartis Found Symp 264: 264-273.
8. Dorner D, Gotzmann J, Foisner R, (2007) Nucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation. FEBS J 274: 1362-1373.
9. Reddy KL, Zullo JM, Bertolino E, Singh H, (2008) Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 452: 243-247.
10. Ellis DJ, Jenkins H, Whitfield WG, Hutchison CJ, (1997) GST-lamin fusion proteins act as dominant negative mutants in Xenopus egg extract and reveal the function of the lamina in DNA replication. J Cell Sci 110 (Pt 20): 2507-2518.
11. Andres V, Gonzalez JM, (2009) Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol 187: 945-957.
12. Benavente R, Krohne G, Franke WW, (1985) Cell type-specific expression of nuclear lamina proteins during development of Xenopus laevis. Cell 41: 177-190.
13. Schatten G, Maul GG, Schatten H, Chaly N, Simerly C, et al. (1985) Nuclear lamins and peripheral nuclear antigens during fertilization and embryogenesis in mice and sea urchins. Proc Natl Acad Sci U S A 82: 4727-4731.
14. Stick R, Hausen P, (1985) Changes in the nuclear lamina composition during early development of Xenopus laevis. Cell 41: 191-200.
15. Frock RL, Kudlow BA, Evans AM, Jameson SA, Hauschka SD, et al. (2006) Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 20: 486-500.
16. Lloyd DJ, Trembath RC, Shackleton S, (2002) A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 11: 769-777.
17. Prokocimer M, Davidovich M, Nissim-Rafinia M, Wiesel-Motiuk N, Bar DZ, et al. (2009) Nuclear lamins: key regulators of nuclear structure and activities. J Cell Mol Med 13: 1059-1085.
18. Capo-Chichi CD, Cai KQ, Smedberg J, Ganjei-Azar P, Godwin AK, et al. (2011) Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer 30: 415-425.
19. Capo-Chichi CD, Cai KQ, Simpkins F, Ganjei-Azar P, Godwin AK, et al. (2011) Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med 9: 28.
20. Belt EJ, Fijneman RJ, van den Berg EG, Bril H, Delis-van Diemen PM, et al. (2011) Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer 47: 1837-1845.
21. Wu Z, Wu L, Weng D, Xu D, Geng J, et al. (2009) Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J Exp Clin Cancer Res 28: 8.
22. Willis ND, Cox TR, Rahman-Casans SF, Smits K, Przyborski SA, et al. (2008) Lamin A/C is a risk biomarker in colorectal cancer. PLoS One 3: e2988.
23. Forloni M, Albini S, Limongi MZ, Cifaldi L, Boldrini R, et al. (2010) NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells. Cancer Res 70: 916-924.
24. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, et al. (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86: 349-363.
25. Riemer D, Stuurman N, Berrios M, Hunter C, Fisher PA, et al. (1995) Expression of Drosophila lamin C is developmentally regulated: analogies with vertebrate A-type lamins. J Cell Sci 108 (Pt 10): 3189-3198.
26. Rober RA, Weber K, Osborn M, (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105: 365-378.
27. Lin F, Worman HJ, (1997) Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. Exp Cell Res 236: 378-384.
28. Michalik L, Wahli W, (2007) Guiding ligands to nuclear receptors. Cell 129: 649-651.
29. Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, et al. (2008) Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res 14: 5348-5356.
30. Yamamoto S, Tsuda H, Honda K, Onozato K, Takano M, et al. (2009) Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod Pathol 22: 499-507.
31. Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, Biedler JL, et al. (2000) The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19: 380-386.
32. Menez J, Le Maux CB, Dorothee G, Vergnon I, Jalil A, et al. (2004) Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene 23: 2630-2639.
33. Zhang Y, Tong X, (2010) Expression of the actin-binding proteins indicates that cofilin and fascin are related to breast tumour size. J Int Med Res 38: 1042-1048.
34. Radhakrishnan VM, Martinez JD, (2010) 14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PLoS One 5: e11433.
35. Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, et al. (2009) 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69: 3425-3432.
36. McHardy LM, Warabi K, Andersen RJ, Roskelley CD, Roberge M, (2005) Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions. Mol Cancer Ther 4: 772-778.
37. Lee JS, Hale CM, Panorchan P, Khatau SB, George JP, et al. (2007) Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys J 93: 2542-2552.
38. Pinol-Roma S, (1997) HnRNP proteins and the nuclear export of mRNA. Semin Cell Dev Biol 8: 57-63.
39. Vlcek S, Foisner R, (2007) A-type lamin networks in light of laminopathic diseases. Biochim Biophys Acta 1773: 661-674.
40. Schirmer EC, (2008) The epigenetics of nuclear envelope organization and disease. Mutat Res 647: 112-121.
41. Shevelyov YY, Lavrov SA, Mikhaylova LM, Nurminsky ID, Kulathinal RJ, et al. (2009) The B-type lamin is required for somatic repression of testis-specific gene clusters. Proc Natl Acad Sci U S A 106: 3282-3287.
42. Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J, et al. (2010) Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res 70: 3249-3258.
43. Trisciuoglio D, Desideri M, Ciuffreda L, Mottolese M, Ribatti D, et al. (2005) Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J Cell Physiol 205: 414-421.
44. Fruci D, Giacomini P, Nicotra MR, Forloni M, Fraioli R, et al. (2008) Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J Cell Physiol 216: 742-749.